quinaprilat has been researched along with Reperfusion Injury in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lazar, HL | 1 |
Faramarzi, S; Grimm, D; Grosse, J; Habighorst, B; Infanger, M; J Danser, AH; Kossmehl, P; Kreutz, R; Kurth, E; Paul, M; Shakibaei, M; Wehland, M | 1 |
Fujita, N; Manabe, H; Masui, Y; Matsumoto, N; Naito, Y; Ochiai, J; Uemura, M; Yoshida, N; Yoshikawa, T | 1 |
3 other study(ies) available for quinaprilat and Reperfusion Injury
Article | Year |
---|---|
Quinaprilat during cardioplegic arrest.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Heart Arrest, Induced; Isoquinolines; Reperfusion Injury; Swine; Tetrahydroisoquinolines | 2003 |
Mechanisms of apoptosis after ischemia and reperfusion: role of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Shape; fas Receptor; Female; Heart; Myocardial Infarction; Myocardium; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Renin-Angiotensin System; Reperfusion Injury; Swine; Tetrahydroisoquinolines; Tumor Suppressor Protein p53 | 2006 |
Inhibition of angiotensin-converting enzyme protects endothelial cell against hypoxia/reoxygenation injury.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aorta; Apoptosis; Bradykinin; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Isoquinolines; L-Lactate Dehydrogenase; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxygen; Reactive Oxygen Species; Reperfusion Injury; Tetrahydroisoquinolines | 2000 |